HIF-1α serves as a co-linker between AD and T2DM - 04/02/24
Abstract |
Alzheimer's disease (AD)-related brain deterioration is linked to the type 2 diabetes mellitus (T2DM) features hyperglycemia, hyperinsulinemia, and insulin resistance. Hypoxia as a common risk factor for both AD and T2DM. Hypoxia-inducible factor-1 alpha (HIF-1α) acts as the main regulator of the hypoxia response and may be a key target in the comorbidity of AD and T2DM. HIF-1α expression is closely related to hyperglycemia, insulin resistance, and inflammation. Tissue oxygen consumption disrupts HIF-1α homeostasis, leading to increased reactive oxygen species levels and the inhibition of insulin receptor pathway activity, causing neuroinflammation, insulin resistance, abnormal Aβ deposition, and tau hyperphosphorylation. HIF-1α activation also leads to the deposition of Aβ by promoting the abnormal shearing of amyloid precursor protein and inhibiting the degradation of Aβ, and it promotes tau hyperphosphorylation by activating oxidative stress and the activation of astrocytes, which further exasperates AD. Therefore, we believe that HIF-α has great potential as a target for the treatment of AD. Importantly, the intracellular homeostasis of HIF-1α is a more crucial factor than its expression level.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Abbreviations : AD, T2DM, GSK3, Aβ, HIF-1, BACE1, VHL, VEGF, GLUT1, EPO, AIH, PHD, NFT, IAPP, AGEs, DNMT3β, APP, CTF, TBI, PP2A, OSAS, IR, PGC-1, COX-2, TNF-α, IL-6, AChEI, NMDAR, CCL2, UPP, vWAT, ATM, DFO, ROS, OS, LTB4, MCP1, APP/PS1, HBOT
Keywords : Alzheimer's disease, Type 2 diabetes, Hypoxia, Hypoxia-inducible factor-1 alpha
Plan
Vol 171
Article 116158- février 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?